Literature DB >> 14618415

Mutation analysis of CBL-C and SPRED3 on 19q in human glioblastoma.

Masahiro Mizoguchi, Catherine L Nutt, David N Louis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14618415     DOI： 10.1007/s10048-003-0164-x

Source DB:  PubMed          Journal:  Neurogenetics        ISSN： 1364-6745            Impact factor:   2.660


× No keyword cloud information.
  6 in total

Review 1.  Negative receptor signalling.

Authors:  Ivan Dikic; Silvia Giordano
Journal:  Curr Opin Cell Biol       Date:  2003-04       Impact factor: 8.382

2.  RING finger mutations that abolish c-Cbl-directed polyubiquitination and downregulation of the EGF receptor are insufficient for cell transformation.

Authors:  C B Thien; F Walker; W Y Langdon
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

3.  cbl-3: a new mammalian cbl family protein.

Authors:  M M Keane; S A Ettenberg; M M Nau; P Banerjee; M Cuello; J Penninger; S Lipkowitz
Journal:  Oncogene       Date:  1999-06-03       Impact factor: 9.867

4.  Spred is a Sprouty-related suppressor of Ras signalling.

Authors:  T Wakioka; A Sasaki; R Kato; T Shouda; A Matsumoto; K Miyoshi; M Tsuneoka; S Komiya; R Baron; A Yoshimura
Journal:  Nature       Date:  2001-08-09       Impact factor: 49.962

5.  Molecular cloning of mammalian Spred-3 which suppresses tyrosine kinase-mediated Erk activation.

Authors:  Reiko Kato; Atsushi Nonami; Takaharu Taketomi; Toru Wakioka; Asato Kuroiwa; Yoichi Matsuda; Akihiko Yoshimura
Journal:  Biochem Biophys Res Commun       Date:  2003-03-21       Impact factor: 3.575

6.  Transcript map of the 3.7-Mb D19S112-D19S246 candidate tumor suppressor region on the long arm of chromosome 19.

Authors:  Christian Hartmann; Loki Johnk; Gaspar Kitange; Yanhong Wu; Linda K Ashworth; Robert B Jenkins; David N Louis
Journal:  Cancer Res       Date:  2002-07-15       Impact factor: 12.701
  6 in total
  4 in total

Review 1.  EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy.

Authors:  Cristina Zahonero; Pilar Sánchez-Gómez
Journal:  Cell Mol Life Sci       Date:  2014-03-27       Impact factor: 9.261

2.  Pathogenesis and prognosis of primary oral squamous cell carcinoma based on microRNAs target genes: a systems biology approach.

Authors:  Amir Taherkhani; Shahab Shahmoradi Dehto; Shokoofeh Jamshidi; Setareh Shojaei
Journal:  Genomics Inform       Date:  2022-09-30

3.  Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth.

Authors:  Natividad Pozo; Cristina Zahonero; Paloma Fernández; Jose M Liñares; Angel Ayuso; Masatoshi Hagiwara; Angel Pérez; Jose R Ricoy; Aurelio Hernández-Laín; Juan M Sepúlveda; Pilar Sánchez-Gómez
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

4.  Spred-3 mutation and Ras/Raf/MAPK activation confer acquired resistance to EGFR tyrosine kinase inhibitor in an EGFR mutated NSCLC cell line.

Authors:  Zhiyong He; Fusheng Gong; Jinrong Liao; Qiang Wang; Ying Su; Chao Chen; Jinghui Lin; Ren-Jang Lin
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.